Literature DB >> 32389231

The EQ-5D-5L Value Set for England: Response to the "Quality Assurance".

Ben van Hout1, Brendan Mulhern2, Yan Feng3, Koonal Shah4, Nancy Devlin5.   

Abstract

OBJECTIVES: To respond to the 'quality assurance' of the EQ-5D-5L value set for England study.
METHODS: We provide a point-by-point response to the issues raised by the authors of the quality assurance paper, drawing on theoretical arguments, empirical analyses and practical considerations.
RESULTS: We provide evidence to show that many of the points made by the authors of the quality assurance are misleading, suggest misunderstandings, or are irrelevant.
CONCLUSIONS: The modeling approaches which were used appropriately address the characteristics of the data and provide a reasonable representation of the average stated preferences of general public in England. We provide reflections on the conduct of stated preference studies, and suggestions for the way forward.
Copyright © 2019 ISPOR–The Professional Society for Health Economics and Outcomes Research. Published by Elsevier Inc. All rights reserved.

Keywords:  EQ-5D; discrete choice experiment; quality assurance; time trade-off; valuation; value set

Year:  2020        PMID: 32389231     DOI: 10.1016/j.jval.2019.10.013

Source DB:  PubMed          Journal:  Value Health        ISSN: 1098-3015            Impact factor:   5.725


  3 in total

1.  Psychometric assessment of EQ-5D-5L and ReQoL measures in patients with anxiety and depression: construct validity and responsiveness.

Authors:  Matthew Franklin; Angel Enrique; Jorge Palacios; Derek Richards
Journal:  Qual Life Res       Date:  2021-04-09       Impact factor: 4.147

2.  NICE and the EQ-5D-5L: Ten Years Trouble.

Authors:  Chris Sampson
Journal:  Pharmacoecon Open       Date:  2021-12-15

3.  An EQ-5D-5L Value Set for Belgium.

Authors:  Nicolas Bouckaert; Irina Cleemput; Stephan Devriese; Sophie Gerkens
Journal:  Pharmacoecon Open       Date:  2022-08-04
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.